News & Analysis as of August 18, 2025

COVID-19

+ Follow

A repository for the most well-read content on JD Supra at any given time, along with occasional roundups of popular content by specific topic. Also stop by for monthly recaps of hot articles for the previous... more +

Regulatory Escalation in Pharma Sector: China Imposes First Executive Sanctions in a Cartel Case

Dacheng on 5/27/2025

On May 9, 2025, the Tianjin Municipal Administration for Market Regulation (“Tianjin AMR”) announced administrative penalties against four manufacturers of dexamethasone sodium phosphate (“DSP”) active pharmaceutical...more

Transportation Cybersecurity and Privacy Under Biden

Holland & Knight LLP on 1/6/2021

President-Elect Joe Biden and Vice President-Elect Kamala Harris will be inaugurated on Jan. 20, 2021, ushering in a new set of regulatory and legislative priorities during the next four years. Chief among the Biden...more

FDA Oversight of Laboratory-Developed Tests Continues To Evolve

Skadden, Arps, Slate, Meagher & Flom LLP on 10/3/2020

On August 19, 2020, the Trump administration made a major announcement that marks the latest development in the ever-evolving saga of the Food and Drug Administration’s (FDA) oversight of laboratory-developed tests (LDTs)....more

Financial Daily Dose 3.5.2020 | Top Story: HP Rejects Xerox’s Hostile Takeover Bid

Robins Kaplan LLP on 3/5/2020

HP has officially rejected Xerox’s enhanced takeover bid, again calling the offer “too low” and decrying its “disproportionate[] benefit” for Xerox shareholders....more

4 Results

View per page

Page: of 1

Today's Popular Updates › Regulatory Oversight › Coronavirus/COVID-19

Regulatory Escalation in Pharma Sector: China Imposes First Executive Sanctions in a Cartel Case

Transportation Cybersecurity and Privacy Under Biden

FDA Oversight of Laboratory-Developed Tests Continues To Evolve

Financial Daily Dose 3.5.2020 | Top Story: HP Rejects Xerox’s Hostile Takeover Bid

"My best business intelligence, in one easy email…"